Search hospitals > Ontario > LONDON
London Health Sciences Centre
Claim this profileLONDON, Ontario N6A 5W9
Global Leader in Prostate Cancer
Global Leader in Cancer
Conducts research for Crohn's Disease
Conducts research for High Blood Pressure
Conducts research for Kidney Disease
616 reported clinical trials
61 medical researchers
Summary
London Health Sciences Centre is a medical facility located in LONDON, Ontario. This center is recognized for care of Prostate Cancer, Cancer, Crohn's Disease, High Blood Pressure, Kidney Disease and other specialties. London Health Sciences Centre is involved with conducting 616 clinical trials across 599 conditions. There are 61 research doctors associated with this hospital, such as Michael Chu, MD, David Palma, MD, Terry Ponich, MD, FRCPC, and Brent Lanting, MD.Area of expertise
1Prostate Cancer
Global LeaderStage IV
Stage II
Stage I
2Cancer
Global LeaderStage IV
p16 positive
p16 negative
Top PIs
Michael Chu, MDLondon Health Sciences Centre3 years of reported clinical research
Studies Coronary Artery Disease
Studies Stroke
17 reported clinical trials
26 drugs studied
David Palma, MDLondon Health Sciences Centre5 years of reported clinical research
Studies Cancer
Studies Head and Neck Cancers
10 reported clinical trials
14 drugs studied
Terry Ponich, MD, FRCPCVictoria Hospital1 year of reported clinical research
Studies Ulcerative Colitis
Studies Inflammatory Bowel Disease
11 reported clinical trials
9 drugs studied
Brent Lanting, MDLondon Health Sciences Centre6 years of reported clinical research
Studies Osteoarthritis
Studies Hip Osteoarthritis
10 reported clinical trials
18 drugs studied
Clinical Trials running at London Health Sciences Centre
Crohn's Disease
Stroke
Ulcerative Colitis
Breast Cancer
Migraine
Blood Clot
Deep Vein Thrombosis
Inflammatory Bowel Disease
Ulcer
Multiple Sclerosis
Vitamin D3
for Crohn's Disease
The purpose of this study is to determine if vitamin D as an adjuvant therapy can improve the outcome (i.e. fewer relapses) and the quality of life, including levels of physical activity, in children diagnosed Crohn's disease (CD).
Recruiting4 awards Phase 3
Vedolizumab
for Ulcerative Colitis and Crohn's Disease
The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Recruiting3 awards Phase 3
Vedolizumab + Adalimumab/Ustekinumab
for Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab together with ustekinumab in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual targeted treatment. The study is conducted in two parts. In Part A, participants will receive the dual targeted treatment (vedolizumab together with either adalimumab or ustekinumab). In part B, participants will receive vedolizumab only. Part B will include participants who responded to the treatment in Part A. Each participant will be followed up for at least 26 weeks after the last dose of treatment.
Recruiting3 awards Phase 410 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at London Health Sciences Centre?
London Health Sciences Centre is a medical facility located in LONDON, Ontario. This center is recognized for care of Prostate Cancer, Cancer, Crohn's Disease, High Blood Pressure, Kidney Disease and other specialties. London Health Sciences Centre is involved with conducting 616 clinical trials across 599 conditions. There are 61 research doctors associated with this hospital, such as Michael Chu, MD, David Palma, MD, Terry Ponich, MD, FRCPC, and Brent Lanting, MD.
Where is London Health Sciences Centre located?
**London Health Sciences Centre**
- **Address:** 339 Windermere Rd, London, ON N5X 2J9, Canada.
- **Transportation:** Accessible via London Transit System Bus Route Richmond #6. Taxis available from the train station directly to the main zone B entrance.
Who should I call to ask about financial aid or insurance network?
For financial assistance at London Health Sciences Centre:
- Contact the Business Office at 519-663-3146 for information on daily hospital rates and finance inquiries related to patient accounts.
- For insurance-related inquiries, call the main telephone line at 519-685-8500. This line connects to various departments, including Emergency Departments, Social Work Services, and Spiritual Care.
- The Patient Relations office is available at 519-685-8500 Extension: 58230 for assistance with patient rights and responsibilities.
What insurance does London Health Sciences Centre accept?
The London Health Sciences Centre (LHSC) accepts a wide range of health insurance plans, including OHIP, extended health insurance, Workplace Safety and Insurance Board, and other legally required agencies. Patients must present a valid Health Card or proof of alternative health insurance, such as UHIP, upon arrival. LHSC also collaborates with organizations across Southwestern Ontario and provincially in shared electronic patient record systems to enhance patient care continuity.
What awards or recognition has London Health Sciences Centre received?
London Health Sciences Centre (LHSC) and Lawson Health Research Institute have been awarded $5.7M in research funding for the Academic Realignment Initiative Awards. This funding is supported by private donors and LHSC's research institute. Lawson Health Research Institute is ranked eighth in Canada for research hospitals and has consistently held a top-five position in Ontario for the past six years.